Top Markets
#1 Official Trump Official Trump +36.17%
#2 Siacoin Siacoin +23.81%
#3 Pump.fun Pump.fun +21.64%
#4 Unit Pump Unit Pump +21.64%
#5 Wrapped STX (Velar) Wrapped STX (Velar) +19.73%
#6 EXOD EXOD +18.93%
#7 Melania Meme Melania Meme +18.52%
#8 MowCat MowCat +18.51%
#9 Mubarak Mubarak +16.80%
#10 Wrapped POL Wrapped POL +16.07%
Coin of the day
Official Trump Official Trump
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Abliva AB (publ) Abliva AB (publ)

Abliva AB (publ)

ABLI
Rang in Aktien #22998
Abliva AB (publ), a Swedish biopharmaceutical company founded in Lund in 2000,... Abliva AB (publ), a Swedish biopharmaceutical company founded in Lund in 2000, focuses on developing innovative therapeutic solutions for primary mitochondrial diseases. Its pipeline includes KL1333, currently in Phase 2/3 clinical trials for the long-term management of these conditions, and NV354, which is preparing for clinical studies targeting primary mitochondrial diseases specifically linked to Complex I deficiency. The company is also advancing NeuroSTAT through a Phase 1b/2a clinical study for the treatment of traumatic brain injury. Abliva maintains strategic partnerships with entities such as Isomerase, Yungjin Pharm, the University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The firm rebranded as Abliva AB (publ) in May 2020, having previously been known as NeuroVive Pharmaceutical AB (publ).
Aktienkurs
$0.04959193
Zuletzt synchronisiert: 2025-03-17
Marktkapitalisierung
$79.94M
Veränderung (1 Tag)
13.49%
Veränderung (1 Jahr)
0.00%
Land
SE
Handel Abliva AB (publ) (ABLI)

Kategorie

Healthcare
EPS für Abliva AB (publ) (ABLI)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Abliva AB (publ) beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Abliva AB (publ) von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH